Atlas Trials

Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites

Clinical trial NCT03697668 · UNKNOWN

Trial details

NCT number
NCT03697668
Sponsor
Nurex S.r.l.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Plasmodium Falciparum Malaria (Drug Resistant)
Start date
2017-09-17
Primary completion
2018-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.